“Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS” (2025) Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025026. doi:10.4084/MJHID.2025.026.